Literature DB >> 6219656

Acromegaly and the heart--echocardiographic and nuclear imaging studies.

J C O'Keefe, S J Grant, J C Wiseman, J N Stiel, E G Wilmshurst, R A Cooper, A C Edwards.   

Abstract

Left ventricular mass (LV mass) and function were assessed in 16 acromegalic patients by echocardiography, and rest and exercise gated blood pool scanning (GBPS) respectively. At the time of study, five patients had active acromegaly, five were hypertensive and three had coexisting coronary artery disease. Increased LV mass was found in six (38%) patients, of whom four were hypertensive and two others had active acromegaly of long duration. One normotensive patient, who did not have coronary disease, had increased LV mass associated with persistently elevated growth hormone (GH) levels for the previous 11 years. Abnormal LV function, as detected by GBPS, occurred only in the three patients with coronary disease. Thus, acromegaly is associated with increased LV mass in hypertensive patients and normotensive patients who have prolonged elevation of GH levels prior to adequate treatment. We found no detectable impairment of LV function, at rest or exercise unless other cardiac disease was present.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6219656     DOI: 10.1111/j.1445-5994.1982.tb02646.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  3 in total

1.  Cardiac function in endocrine diseases: I. Acromegaly.

Authors:  R Griebenow; L Krämer; U Frangenberg; B Allolio; D Kaulen; F Saborowski; W Winkelmann
Journal:  Klin Wochenschr       Date:  1989-11-17

2.  Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle.

Authors:  E A Rodrigues; M P Caruana; A Lahiri; J D Nabarro; H S Jacobs; E B Raftery
Journal:  Br Heart J       Date:  1989-09

Review 3.  Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review.

Authors:  Maryam Heidarpour; Davood Shafie; Ashraf Aminorroaya; Nizal Sarrafzadegan; Ziba Farajzadegan; Rasool Nouri; Arash Najimi; Christina Dimopolou; Gunter Stalla
Journal:  J Res Med Sci       Date:  2019-04-26       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.